A prodrug form of 7,8-dihydroxyflavone
Related Products
Active Metabolite(s)
169467,8-Dihydroxyflavone
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

TrkB Agonist Prodrug R13

Item No. 42074

Technical Information
Formal Name
7,8-bis[[(methylamino)carbonyl]oxy]-2-phenyl-4H-1-benzopyran-4-one
CAS Number
1609067-49-3
Synonyms
  • TrkB-IN-1
  • Tropomyosin-related Kinase B Agonist Prodrug R13
  • Tropomyosin-related Kinase B Inhibitor 1
Molecular Formula
C19H16N2O6
Formula Weight
Purity
≥95%
Formulation
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/mlDMSO: Slightly soluble: 0.1-1 mg/mlWater: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(NC)OC1=C(OC(C2=CC=CC=C2)=CC3=O)C3=CC=C1OC(NC)=O
InChi Code
InChI=1S/C19H16N2O6/c1-20-18(23)26-14-9-8-12-13(22)10-15(11-6-4-3-5-7-11)25-16(12)17(14)27-19(24)21-2/h3-10H,1-2H3,(H,20,23)(H,21,24)
InChi Key
NWWRHMSYZTWUBD-UHFFFAOYSA-N
Origin
Synthetic
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone (Item No. 16946).1 Oral administration of R13 (43.6 mg/kg per day) increases hippocampal phosphorylated levels of TrkB, ERK, and Akt in the 5XFAD transgenic mouse model of Alzheimer's disease. It decreases the number of malformed neurons and increases the number of neurons and active synapses in the hippocampus in 5XFAD mice. R13 decreases the number of plaques and levels of amyloid-β (1-40) (Aβ40) in the hippocampus and frontal cortex and escape latency in the Morris water maze in 5XFAD mice. It reduces the levels and activity of δ-secretase, also known as asparagine endopeptidase (Aep) and legumain, and the levels of Il-6, Tnf-α, and Il-1β in brain homogenates from 5XFAD mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, C., Wang, Z., Zhang, Z., et alThe prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease. Proc. Natl. Acad. Sci. U S A 115(3), 578-583 (2018).